Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Mood-Related Side Effects : Clinical trials of semaglutide have reported some cases of anxiety, depression, or mood changes
Industry Size (2026) USD 2.9 Bn Forecast (2036) USD 7.8 Bn CAGR (2026 to 2036) 11.7% GLP-1 Receptor Agonist Market Size, Market Forecast and Outlook By FMI The GLP-1 receptor agonist market is expected to expand from USD 2.9 billion in 2026 to USD 7.8 billion by 2036
Ultimately, sustained weight management and health improvements can reinforce personal well-being
CJC-1295 / Ipamorelin side effects Reported effects and what the studies actually measured